Asprosin, a prospective biomarker for rhabdomyolysis-induced acute kidney damage in rats: involvement of PKA/TGF-β1/SMAD-3 signaling pathway
Khalil, S., Abd El-Fatah, S., Fathy, M., Elwany, N., Ahmad, E., Mohamed, N., Habib, M. (2023). Asprosin, a prospective biomarker for rhabdomyolysis-induced acute kidney damage in rats: involvement of PKA/TGF-β1/SMAD-3 signaling pathway. EKB Journal Management System, 29(4), 1146-1160. doi: 10.21608/zumj.2023.209146.2796
Sama Salah Khalil; Samaa Salah Abd El-Fatah; Maha Abdelhamid Fathy; N E. Elwany; Enssaf Ahmad Ahmad; Noura Mostafa Mohamed; Marwa A Habib. "Asprosin, a prospective biomarker for rhabdomyolysis-induced acute kidney damage in rats: involvement of PKA/TGF-β1/SMAD-3 signaling pathway". EKB Journal Management System, 29, 4, 2023, 1146-1160. doi: 10.21608/zumj.2023.209146.2796
Khalil, S., Abd El-Fatah, S., Fathy, M., Elwany, N., Ahmad, E., Mohamed, N., Habib, M. (2023). 'Asprosin, a prospective biomarker for rhabdomyolysis-induced acute kidney damage in rats: involvement of PKA/TGF-β1/SMAD-3 signaling pathway', EKB Journal Management System, 29(4), pp. 1146-1160. doi: 10.21608/zumj.2023.209146.2796
Khalil, S., Abd El-Fatah, S., Fathy, M., Elwany, N., Ahmad, E., Mohamed, N., Habib, M. Asprosin, a prospective biomarker for rhabdomyolysis-induced acute kidney damage in rats: involvement of PKA/TGF-β1/SMAD-3 signaling pathway. EKB Journal Management System, 2023; 29(4): 1146-1160. doi: 10.21608/zumj.2023.209146.2796